Health Care Challenges in the Management of Primary Aldosteronism in Southeast Asia
Authors' conclusion
Large populations currently do not have access to the health care resources required for the optimal management of PA. Greater efforts are required to improve health care access and affordability. Future guideline revisions for PA may need to consider these limitations.
Study context
- Population
- Specialists managing primary aldosteronism (PA) in Association of Southeast Asian Nations (ASEAN) countries, incl. low-middle-income countries
- Participants
- 48 participants9 ASEAN countries
- Outcome
- Availability and affordability of health care resources (investigations and treatment) for managing PA
Methodological detailsquestionnaire-based survey of specialists, Population and income status data from national census and registries
- Questionnaire-based survey of specialists
- Population and income status data from national census and registries
Main finding
As reported in the abstract
Availability and affordability of PA investigations and treatment
- Countries performing screening with aldosterone-renin ratio
- all countries
- Countries routinely performing confirmatory testing (lack of facilities and local assays, cost constraint)
- 6 countries
- Countries with locally available assays; some centres with test turnaround >3 weeks
- 4 countries
- Countries where adrenal vein sampling (AVS) not routinely performed (insufficient radiological facilities or trained personnel, cost constraint); combined population 442 million
- 7 countries
- Countries where cost of AVS and adrenalectomy combined >30% of annual gross domestic product per capita
- 6 countries
Observational data: associations, not effects.
Original publication
Health Care Challenges in the Management of Primary Aldosteronism in Southeast Asia. J Clin Endocrinol Metab. Published 23 January 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →